Schweikart Scott J
A senior research associate for the American Medical Association Council on Ethical and Judicial Affairs in Chicago, Illinois, and the legal editor for the AMA Journal of Ethics.
AMA J Ethics. 2019 Jul 1;21(7):E587-593. doi: 10.1001/amajethics.2019.587.
Unrepresented patients are those who have no surrogate or advance directive to guide medical decision making for them when they become incapacitated. While there is no perfect solution to the problem of making medical decisions for such vulnerable patients, 3 different approaches are noted in the literature: a physician approach, an ethics committee approach, and a guardianship approach. Recent policies and laws have required an approach that is "tiered" with respect to both who is involved and the gravity of the medical treatment questions at issue. In a general sense, some variant of a tiered approach is likely the best possible solution for jurisdictions and health institutions-both those already with and those without a tiered approach-to the challenging puzzle of treating unrepresented patients.
无代理人患者是指那些在丧失行为能力时没有代理人或预先指示来指导为其进行医疗决策的患者。虽然对于为这类弱势患者做出医疗决策的问题没有完美的解决方案,但文献中提到了三种不同的方法:医生主导法、伦理委员会主导法和监护法。最近的政策和法律要求采用一种在参与人员以及所涉医疗问题的严重性方面都“分层”的方法。一般来说,某种分层方法的变体可能是各司法管辖区和卫生机构——无论已经采用分层方法还是未采用分层方法——处理无代理人患者这一具有挑战性难题的最佳解决方案。